Evidence map›Paper›PMID 41838267›Full record

ArticleApplied biochemistry and biotechnology2026

A Novel 3D Microflow Support for the Immobilization of Phospholipase D and Efficient Biphasic Transphosphatidylation.

Neng-Bing Long, Hong-Lin Zhu, Tian-Hua Li, Rui-Feng Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neng-Bing LongFaculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315211, PR China.ORCID http://orcid.org/0000-0001-5822-9412
Hong-Lin ZhuFaculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315211, PR China.
Tian-Hua LiFaculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315211, PR China.
Rui-Feng ZhangFaculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang, 315211, PR China. zhangruifeng@nbu.edu.cn.

Funding

K. C. Wong Magna Fund in Ningbo University K. C. Wong Magna Fund in Ningbo University
6 · The paper itself

Abstract

A large-sized 3D microflow support was prepared by chemical liquid deposition of an epoxy-based porous polymer within a 3D melamine sponge. This novel support demonstrated advantages over traditional microfluidic reactors in terms of easier scalability, simplified enzyme loading, and superior multiphase dispersion. The resultant composite sponge was utilized as a microflow support for the immobilization of phospholipase D (PLD) through an adsorption and cross-linking method. Under optimal immobilization conditions, the loading capacity and specific activity of the immobilized PLD were 50.2 mg/g support and 14.5 U/mg protein, respectively. The PLD-immobilized microflow supports were positioned in a columnar reactor, where a biphasic transesterification reaction was conducted in a continuous circulation mode powered by two pumps. The PLD-catalyzed reaction yielded phosphatidylserine (PS) with high yields and reaction ratios. Under optimized conditions, the PS yield reached as high as 93.1% within 4 h at 45 °C, by using free PLD the PS yield reached only 61.5% within 12 h. After 10 cycles, the immobilized PLD retained 76% of its original activity.

Indexed as

Enzymes, ImmobilizedPhosphatidylserinesPhospholipase DPorosityEnzymes, ImmobilizedPhosphatidylserinesPhospholipase DBiphasic reactionChemical liquid depositionMicroflow supportPhosphatidylserinePhospholipase D

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.